News バイオ技術パイプラインの最新情報 — 2014年 2015年2月1日 Nature Biotechnology 33, 2 doi: 10.1038/nbt.3136 Approvals of new chemical and biologic entities surged again in 2014, shepherded along by a confident FDA, as industry reaped the rewards of drug development incentives. Chris Morrison reports. Full text PDF 目次へ戻る
